NO20073395L - Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer - Google Patents

Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer

Info

Publication number
NO20073395L
NO20073395L NO20073395A NO20073395A NO20073395L NO 20073395 L NO20073395 L NO 20073395L NO 20073395 A NO20073395 A NO 20073395A NO 20073395 A NO20073395 A NO 20073395A NO 20073395 L NO20073395 L NO 20073395L
Authority
NO
Norway
Prior art keywords
gastric
coating composition
composition containing
resistant
sticking agent
Prior art date
Application number
NO20073395A
Other languages
English (en)
Inventor
George Reyes
Thomas Farrell
Kurt Fegely
Ali Rajabi-Siahboomi
Budhi Simon
Cara Young
Original Assignee
Bpsi Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36588225&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20073395(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bpsi Holdings Inc filed Critical Bpsi Holdings Inc
Publication of NO20073395L publication Critical patent/NO20073395L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/501—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)

Abstract

Tørre, enteriske filmbelegningsblandinger og vandige dispersjoner inneholdende de samme er beskrevet. Når de er påført oralt inntakbare substrater som for eksempel orale faste doseformer er filmbeleggene i stand til å hindre at substratene desintegrerer i media med pH verdier fra omtrent 1 til omtrent 4,5 eller høyere verdier. En foretrukket filmbelegningsblanding inneholder et mikronisert mellomprodukt bestående av en akrylharpiks og talkum. Fordelaktig og overraskende inneholder den foretrukne filmbelegningsblanding ikke et alkaliserende middel.
NO20073395A 2004-12-17 2007-07-02 Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer NO20073395L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63708304P 2004-12-17 2004-12-17
PCT/US2005/046326 WO2006066264A1 (en) 2004-12-17 2005-12-16 Enteric film coating composition containing enteric polymer micronized with detackifier

Publications (1)

Publication Number Publication Date
NO20073395L true NO20073395L (no) 2007-09-07

Family

ID=36588225

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073395A NO20073395L (no) 2004-12-17 2007-07-02 Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer

Country Status (15)

Country Link
US (1) US20060134216A1 (no)
EP (1) EP1827390A1 (no)
JP (1) JP2008524257A (no)
KR (1) KR20070094627A (no)
CN (1) CN101080217B (no)
AR (1) AR051722A1 (no)
AU (1) AU2005316235A1 (no)
BR (1) BRPI0518575A2 (no)
CA (1) CA2586425A1 (no)
IL (1) IL183579A0 (no)
MX (1) MX2007007221A (no)
NO (1) NO20073395L (no)
TW (1) TW200626185A (no)
WO (1) WO2006066264A1 (no)
ZA (1) ZA200704311B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2051704T1 (sl) * 2006-08-18 2012-08-31 Evonik Roehm Gmbh Farmacevtski sestavek s kontroliranim sproščanjem aktivne učinkovine za aktivne učinkovine z dobro topnostjo v vodi
KR20120033305A (ko) * 2009-05-12 2012-04-06 비피에스아이 홀딩스, 엘엘씨. 미립자인 비점착제를 포함하는 필름 코팅 및 상기 필름코팅이 코팅된 기재
AU2010248060A1 (en) * 2009-05-12 2011-10-27 Bpsi Holdings, Llc. Enhanced moisture barrier immediate release film coating systems and substrates coated therewith
EA030433B1 (ru) * 2010-04-30 2018-08-31 Такеда Фармасьютикал Компани Лимитед Энтеросолюбильная таблетка
RU2593771C2 (ru) * 2010-04-30 2016-08-10 Такеда Фармасьютикал Компани Лимитед Энтеросолюбильная таблетка
WO2014159814A1 (en) * 2013-03-13 2014-10-02 Patricia Oliver Formulations and tablets for treatment or prevention of neurological disorders
US11433146B2 (en) 2015-06-12 2022-09-06 Vaxart, Inc. Formulations for small intestinal delivery of RSV and norovirus antigens
CA3093120A1 (en) * 2018-04-12 2019-10-17 Bpsi Holdings Llc Acidifying coatings and disintegration-resistant substrates coated therewith
US11458104B1 (en) 2018-06-21 2022-10-04 Mission Pharmacal Company Enteric coated tiopronin tablet
CN116617174B (zh) * 2023-05-12 2024-03-08 石家庄四药有限公司 一种含硫酸氢氯吡格雷和阿司匹林的片剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US656457A (en) * 1900-05-11 1900-08-21 Isaac Hirsch Knife.
US2595076A (en) * 1949-09-19 1952-04-29 Hudson Bay Mining & Smelting Selective flotation of zinc
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
CN1162917A (zh) * 1994-10-07 1997-10-22 伯温德药品服务公司 肠内涂层组合物，用其涂覆的方法和涂覆制品
PL186605B1 (pl) * 1995-09-21 2004-01-30 Pharma Pass Llc Tabletka lub mikrotabletka zawierająca rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol oraz sposób wytwarzania tabletek lub mikrotabletek zawierających rdzeń posiadający jako kwasolabilny składnik aktywny omeprazol
US6623759B2 (en) * 1996-06-28 2003-09-23 Astrazeneca Ab Stable drug form for oral administration with benzimidazole derivatives as active ingredient and process for the preparation thereof
KR20030025903A (ko) * 2000-02-10 2003-03-29 비피에스아이 홀딩스, 인코포레이션. 아크릴 장용 코팅 조성물
US6420473B1 (en) * 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
US6500457B1 (en) * 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
US6749867B2 (en) * 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
US6703004B2 (en) * 2002-04-03 2004-03-09 Revlon Consumer Products Corporation Method and compositions for bleaching hair
US20040255399A1 (en) * 2003-06-23 2004-12-23 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Method and compositions for coloring hair with taurate copolymers

Also Published As

Publication number Publication date
WO2006066264A1 (en) 2006-06-22
CN101080217A (zh) 2007-11-28
IL183579A0 (en) 2007-09-20
CN101080217B (zh) 2012-07-18
US20060134216A1 (en) 2006-06-22
JP2008524257A (ja) 2008-07-10
AU2005316235A1 (en) 2006-06-22
CA2586425A1 (en) 2006-06-22
ZA200704311B (en) 2008-06-25
KR20070094627A (ko) 2007-09-20
AR051722A1 (es) 2007-01-31
EP1827390A1 (en) 2007-09-05
TW200626185A (en) 2006-08-01
BRPI0518575A2 (pt) 2009-04-28
MX2007007221A (es) 2007-08-14

Similar Documents

Publication Publication Date Title
NO20073395L (no) Magesaftresistent beleggsammensetning som inneholder magesaftresistent polymer mikronisert med en ikke-klebriggjorer
MXPA05008491A (es) Sistemas de recubrimiento de pelicula nacarada y substratos recubiertos con la misma.
MX2009003821A (es) Compuestos de n-aril pirazol para usarse contra la diabetes.
WO2008002573A3 (en) Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated deseases or conditions
MA31433B1 (fr) Inhibiteurs de la p70 s6 kinase
HK1062677A1 (en) 17Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
MY144209A (en) Pyridazine derivatives as 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
MX2007008141A (es) Composicion farmaceutica de sustancias labiles en medio acido.
EP2260835A3 (en) Composition for proteasome inhibition
RS51607B (sr) Novi lekovi za tretiranje hroničnog opstruktivnog oboljenja pluća
MX2008013040A (es) Derivados de bencimidazol 5-sulfonamida como ligandos del receptor cannabinoide 1.
IL178128A0 (en) Salts of 3-0-(3',3'-dimethyl-succinyl) betulinic acid and pharmaceutical compositions containing the same
ATE551988T1 (de) Orale zusammensetzungen, ihre herstellung und verwendung
WO2009021750A3 (en) Benzoxazole, benzimidazole and benzothiazole derivatives and their use in the treatment of duchenne muscular dytrophy
UA90742C2 (en) Pyrazolone derivatives
NO20072915L (no) Farmasoytisk preparat som inneholder belagte magnetiske partikler og fremgangsmate for fremstilling av disse, og diagnoseterapisystem
UA95715C2 (ru) Фосфадиазиновые производные, фармацевтическая композиция и их применение
NO20076515L (no) Hydantoinforbindelser
WO2006125181A3 (en) Piperidine derivatives and their use as stearoyl-coa desaturase modulators
MX2009003169A (es) Derivados de sulfonamida.
NO20080750L (no) (Indol-3-YL)-heterocykelderivater som agonister av cannabinoid CB1 reseptor
CL2003002356A1 (es) Compuestos derivados de 1-(1-acetil-piperidin-4-il)-(ester o amida)-4-(bencidrilo sustituido)-2-tert-butil-piperazina, composicion farmaceutica, y su uso en la inhibicion de 17b-hidroxiesteroide deshidrogenasa de tipo 3 y de enfermedades que dependen
BRPI0514415A (pt) composto, composição farmacêutica, e, uso de um composto
WO2007016201A3 (en) FORMULATION OF RADIOPROTECTIVE α, β UNSATURATED ARYL SULFONES
NO20080034L (no) Benzotiazol-2-on derivater som lipase og fosfolipaseinhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application